Observations placeholder
Prandin
Identifier
015663
Type of Spiritual Experience
Background
A description of the experience
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. It is sold by Novo Nordisk under the name of Prandin in the U.S., GlucoNorm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.
On Mar, 10, 2015: 3,413 people reported to have side effects when taking Prandin. Among them, 23 people (0.67%) have Hallucination.
Time on Prandin when people have Hallucination :
n/a |
Gender of people who have Hallucination when taking Prandin :
Female | Male | |
Hallucination | 78.26% | 21.74% |
Age of people who have Hallucination when taking Prandin :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 18.75% | 12.50% | 18.75% | 50.00% |
On Jan, 15, 2017 3,964 people reported to have side effects when taking Prandin.
Among them, 75 people (1.89%) have Death